Does a single daily dose of acetylsalicylic acid reduce reinfarction and total mortality in men with a recent myocardial infarction?
A single daily dose of aspirin in men with a recent myocardial infarction yielded inconclusive results for preventing reinfarction but suggested a potential reduction in total mortality at 6 and 12 months.
The results of a randomized controlled trial of a single daily dose of acetyl salicylic acid (aspirin) in the prevention of reinfarction in 1,239 men who had had a recent myocardial infarct were statistically inconclusive. Nevertheless, they showed a reduction in total mortality of 12% at six months and 25% at twelve months after admission to the trial. Further trials are urgently required to establish whether or not this effect is real.
Elwood et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: